Freeline Therapeutics
Biopharmaceutical company that developed liver-directed AAV gene therapies for hemophilia and other diseases. Ceased operations and entered administration in 2023 after clinical setbacks.
Location
Stevenage, United Kingdom
Founded
2015
Investors
1
Categories
gene-therapy, biotech, liver-directed, hemophilia, defunct
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| AlbionVC (Healthcare) | London, UK | biotech-focused | seedseries-a+1 | 17 |